NOTICE OF ALLOWANCE - ISSUED
issued
on 15 Oct 2024
Last Applicant/ Owned by
Suite 6-401
Cambridge
MA
02139
Serial Number
98305479 filed on 08th Dec 2023
Registration Number
N/A
Correspondent Address
Tiffany D. Gehrke
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
KORRO
Pharmaceutical research and development; Pharmaceutical research and development in the fields of gene therapies, gene editing, drug discovery and development; Pharmaceutical research and development incorporating artificial intelligence; Pharmaceutical research and development incorporating genetic learning; Scientific and industrial research; Scientific and industrial research incorporating arti Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical research and development; Pharmaceutical research and development in the fields of gene therapies, gene editing, drug discovery and development; Pharmaceutical research and development incorporating artificial intelligence; Pharmaceutical research and development incorporating genetic learning; Scientific and industrial research; Scientific and industrial research incorporating artificial intelligence; Scientific and industrial research in the field of gene therapies, gene editing, drug discovery and development incorporating genetic learning; Medical and scientific research in the field of pharmaceuticals, genetics, gene editing, and genetic diseases
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [040]
Treatment & Processing of Materials Services
Custom manufacture of biomedical compounds comprised of nucleotide polymers and biomedical compounds comprised of ribonucleic acid polymers all for use in genetic research, pharmaceutical therapies, medical research and treatment of various conditions and disorders for others; Custom manufacture and processing of human cells for medical purposes for others; Treatment of therapeutic cells for others, namely, pharmacological treatment and processing of therapeutic cells to modify their function for therapeutic purposes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of genetic diseases; Pharmaceutical products for cell therapy to treat genetic diseases; Medical and scientific research in the field of pharmaceuticals, genetics, gene editing, and genetic diseases
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98305479
Mark Type
No Service Mark
Attorney Docket Number
No 33791/60006
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 15th Oct 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 20th Aug 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 20th Aug 2024 | PUBLISHED FOR OPPOSITION |
| 31st Jul 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 16th Jul 2024 | EXAMINERS AMENDMENT -WRITTEN |
| 16th Jul 2024 | EXAMINER'S AMENDMENT ENTERED |
| 16th Jul 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 16th Jul 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 16th Jul 2024 | EXAMINERS AMENDMENT E-MAILED |
| 09th Jul 2024 | ASSIGNED TO EXAMINER |